|
시장보고서
상품코드
1935125
수의용 API 시장 : 종류별, 동물 종류별, 제제별, 치료 용도별, 투여 경로별, 제조 유형별, 판매 채널별, 지역별Veterinary API Market, By Type, By Animal Type, By Formulation, By Therapeutic Application, By Route of Administration, By Manufacturing Type, By Sales Channel, By Geography |
||||||
수의용 API 시장은 2026년에 99억 7,000만 달러로 추정되며, 2033년까지 164억 3,000만 달러에 달할 것으로 예측됩니다. 2026년부터 2033년까지 CAGR 7.4%로 성장할 전망입니다.
| 보고서 내용 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도: | 2025년 | 2026년 시장 규모: | 99억 7,000만 달러 |
| 과거 데이터 기간: | 2020-2024년 | 예측 기간: | 2026-2033년 |
| 예측 기간 2026-2033년 CAGR: | 7.40% | 2033년 예측치: | 164억 3,000만 달러 |
세계 수의학 API 시장은 수의학 의약품을 제조하는 데 사용되는 기초 화학 화합물 및 생물학적 물질을 포함하는 광범위한 헬스케어 산업에서 중요한 부문입니다. 수의용 API는 반려동물, 가축, 양식업 종의 질병 치료, 예방, 관리를 목적으로 하는 의약품의 주요 치료 성분으로 작용합니다.
이 시장은 동물 건강에 대한 인식 증가, 반려동물 사육률 증가, 동물성 단백질 소비에 대한 수요 증가, 식품 안전 및 동물 복지 기준에 대한 엄격한 규제 시행으로 인해 그 중요성이 더욱 커지고 있습니다. 수의학 API 분야는 항감염제, 구충제, 항염증제, 마취제, 호르몬제 등 다양한 카테고리로 구성되어 있으며, 각 카테고리는 수의학의 특정 치료 요구에 대응하고 있습니다.
시장 역학은 인수공통전염병의 출현, 수의학 연구의 발전, 세계 식량 수요를 충족시키기 위한 축산 증가, 반려동물의 인간화 추세 증가 등의 요인에 의해 영향을 받고 있습니다. 또한, 동물용 의약품의 개발 및 승인 과정을 규정하는 규제 프레임워크는 각 지역의 시장 성장 패턴과 경쟁 구도를 형성하는 데 중요한 역할을 합니다.
시장 역학
세계 동물용 API 시장의 성장은 반려동물 사육 수의 급증과 반려동물 의료비 지출 증가에 의해 주도되고 있습니다. 반려동물 보호자들이 동물을 가족의 일원으로 여기고 양질의 의료 서비스를 원하는 경향이 강해졌기 때문입니다. 전 세계 육류 소비량 증가와 축산업 확대에 따라 동물의 건강관리 강화가 요구되고 있으며, 동물 복지와 식품 안전 기준을 보장하기 위한 수의용 API에 대한 수요가 증가하고 있습니다.
의약품 제조의 혁신, 특히 동물을 위한 새로운 약물전달 시스템 및 정밀 의료 접근법의 개발은 새로운 성장 기회를 창출하고 있습니다. 그러나 시장에는 심각한 제약도 존재합니다. 엄격한 규제 프레임워크로 인해 광범위한 임상시험과 장기간의 승인 절차가 요구되어 신규 동물용 의약품 원료를 시장에 출시하는 데 소요되는 시간과 개발 비용이 증가하고 있습니다.
위조품 및 비규격 동물용 의약품의 존재는 특히 신흥 시장에서 심각한 문제가 되고 있으며, 시장의 신뢰성과 환자의 안전에 영향을 미치고 있습니다. 또한, 지방 및 개발도상국의 수의사 부족은 시장 침투와 양질의 수의학에 대한 접근성을 제한하고 있습니다.
이러한 도전과제가 있는 반면, 신흥시장 확대라는 큰 기회도 존재합니다. 가처분 소득의 증가와 동물의 건강관리에 대한 인식이 높아지면서 미개척의 가능성을 창출하고 있는 것입니다. 양식용 API 개발은 전 세계적으로 양식업이 계속 확대되고 있는 가운데 큰 성장 기회를 보여주고 있습니다. 또한, 동물의 예방적 건강관리에 대한 관심이 높아지고 유기농 및 천연 동물용 제품에 대한 수요가 증가함에 따라 API 개발 및 시장 확대의 새로운 길이 열리고 있습니다.
본 조사의 주요 특징
- 세계의 수의학 API 시장에 대한 상세한 분석과 2025년을 기준 연도, 예측 기간(2026-2033년)의 시장 규모(10억 달러)와 연평균 성장률(CAGR)을 조사하여 전해드립니다.
- 각 부문의 잠재적 수익기회를 확인하고, 이 시장의 매력적인 투자 제안 매트릭스에 대해 설명합니다.
- 시장 촉진요인, 저해요인, 기회, 신제품 출시 또는 승인, 시장 동향, 지역별 전망, 주요 업체들의 경쟁 전략에 대한 중요한 정보도 제공합니다.
- 이 보고서에서는 회사 개요, 제품 포트폴리오, 주요 특징, 재무 성과, 전략 등 다양한 매개 변수를 기반으로 세계 수의학 API 시장의 주요 기업 프로파일을 제공합니다.
- 이 보고서는 마케팅 담당자 및 기업 경영진이 향후 제품 출시, 유형 업그레이드, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있도록 돕습니다.
- 이 세계 수의학 API 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 재무 분석가 등 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 수의용 API 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 가정
제2장 시장 범위
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 수의용 원료의약품 시장 : 종류별, 2021-2033년
제5장 세계의 수의용 API 시장 : 동물 종류별, 2021-2033년
제6장 세계의 수의용 API 시장 : 제제별, 2021-2033년
제7장 세계의 수의용 API 시장 : 치료 용도별, 2021-2033년
제8장 세계의 수의용 API 시장 : 투여 경로별, 2021-2033년
제9장 세계의 수의용 원료의약품 시장 : 제조 유형별, 2021-2033년
제10장 세계의 수의용 API 시장 : 판매 채널별, 2021-2033년
제11장 세계의 수의용 API 시장 : 지역별, 2021-2033년
제12장 경쟁 구도
제13장 애널리스트의 추천사항
제14장 참고문헌 및 조사 방법
KSMVeterinary API Market is estimated to be valued at USD 9.97 Bn in 2026 and is expected to reach USD 16.43 Bn by 2033, growing at a compound annual growth rate (CAGR) of 7.4% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 9.97 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 7.40% | 2033 Value Projection: | USD 16.43 Bn |
The global veterinary API market represents a critical segment within the broader animal healthcare industry, encompassing the fundamental chemical compounds and biological substances used in the formulation of veterinary medicines. Veterinary APIs serve as the primary therapeutic components in medications designed to treat, prevent, and manage diseases across companion animals, livestock, and aquaculture species.
This market has gained significant prominence due to the increasing awareness of animal health, rising pet ownership rates, growing demand for animal protein consumption, and the implementation of stringent regulations regarding food safety and animal welfare standards. The veterinary API landscape comprises various categories including anti-infectives, parasiticides, anti-inflammatory agents, anesthetics, and hormones, each addressing specific therapeutic needs within veterinary medicine.
The market dynamics are influenced by factors such as the emergence of zoonotic diseases, advancement in veterinary pharmaceutical research, increasing livestock production to meet global food demand, and the growing trend of pet humanization. Additionally, the regulatory framework governing veterinary drug development and approval processes plays a crucial role in shaping market growth patterns and competitive landscapes across different geographical regions.
Market Dynamics
The global veterinary API market growth is primarily driven by the exponential growth in pet ownership and the increasing expenditure on companion animal healthcare, as pet owners increasingly view their animals as family members requiring premium medical care. The rising global meat consumption and expanding livestock industry necessitate enhanced animal health management, driving demand for veterinary APIs to ensure animal welfare and food safety standards.
Technological advancements in pharmaceutical manufacturing, including the development of novel drug delivery systems and precision medicine approaches for animals, are creating new growth opportunities. However, the market faces significant restraints including stringent regulatory frameworks that require extensive clinical trials and lengthy approval processes, increasing the time-to-market and development costs for new veterinary APIs.
The presence of counterfeit and substandard veterinary medicines poses serious challenges, particularly in emerging markets, affecting market credibility and patient safety. Additionally, the limited number of veterinarians in rural areas and developing regions restricts market penetration and accessibility to quality veterinary care.
Despite these challenges, substantial opportunities exist in the form of emerging markets expansion, where increasing disposable income and growing awareness about animal health are creating untapped potential. The development of APIs for aquaculture applications presents significant growth prospects as fish farming continues to expand globally. Furthermore, the increasing focus on preventive healthcare in animals, coupled with the growing trend of organic and natural veterinary products, opens new avenues for API development and market expansion.
Key Features of the Study
- This report provides in-depth analysis of the global veterinary API market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2026-2033), considering 2025 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global veterinary API market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Zoetis Inc, SUANFARMA S.A, Grupo Indukern S.L, Sequent Scientific Limited, Ofichem Group, Alivira Animal Health Limited, Excel Industries Ltd, Chempro Pharma Private Limited, NGL Fine Chem Ltd, FIS - Fabbrica Italiana Sintetici S.p.A, AMGIS Lifescience Ltd, Huvepharma AD, Vetpharma Animal Health S.L, Qilu Animal Health Products Co Ltd, and Menadiona
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global veterinary API market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global veterinary API market
Market Segmentation
- Type Insights (Revenue, USD Bn, 2021 - 2033)
- Anti infectives
- Anti inflammatory Drugs
- Antiparasitic Agents
- Hormones and Steroids
- Vitamins and Nutrients
- Anesthetics
- Others (e.g., Dermatological APIs, Electrolytes)
- Animal Type Insights (Revenue, USD Bn, 2021 - 2033)
- Companion Animals
- Dogs
- Cats
- Others (e.g., rabbits, birds)
- Livestock
- Cattle
- Swine
- Poultry
- Sheep and Goats
- Others (e.g., equine)
- Formulation Insights (Revenue, USD Bn, 2021 - 2033)
- Solid
- Tablets
- Capsules
- Powders
- Semi solid
- Ointments
- Gels
- Liquid
- Injectables
- Oral Solutions/Suspensions
- Therapeutic Application Insights (Revenue, USD Bn, 2021 - 2033)
- Infectious Disease Management
- Pain/Inflammation Management
- Parasitic Control
- Metabolic and Endocrine Disorders
- Reproductive Health
- Nutritional Support
- Anesthesia/Sedation
- Others (e.g., Dermatology)
- Route of Administration Insights (Revenue, USD Bn, 2021 - 2033)
- Oral
- Parenteral
- Topical
- Mucosal
- Manufacturing Type Insights (Revenue, USD Bn, 2021 - 2033)
- Contract Manufacturing
- In house Manufacturing
- Sales Channel Insights (Revenue, USD Bn, 2021 - 2033)
- Online
- Offline
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Zoetis Inc
- SUANFARMA S.A
- Grupo Indukern S.L
- Sequent Scientific Limited
- Ofichem Group
- Alivira Animal Health Limited
- Excel Industries Ltd
- Chempro Pharma Private Limited
- NGL Fine Chem Ltd
- FIS - Fabbrica Italiana Sintetici S.p.A
- AMGIS Lifescience Ltd
- Huvepharma AD
- Vetpharma Animal Health S.L
- Qilu Animal Health Products Co Ltd
- Menadiona
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Veterinary API Market, By Type
- Global Veterinary API Market, By Animal Type
- Global Veterinary API Market, By Formulation
- Global Veterinary API Market, By Therapeutic Application
- Global Veterinary API Market, By Route of Administration
- Global Veterinary API Market, By Manufacturing Type
- Global Veterinary API Market, By Sales Channel
- Global Veterinary API Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Market Opportunities
- Regulatory Scenario
- Key Developments
- Industry Trends
4. Global Veterinary API Market, By Type, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Anti infectives
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Anti inflammatory Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Antiparasitic Agents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Hormones and Steroids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Vitamins and Nutrients
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Anesthetics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others (e.g., Dermatological APIs, Electrolytes)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
5. Global Veterinary API Market, By Animal Type, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Companion Animals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Dogs
- Cats
- Others (e.g., rabbits, birds)
- Livestock
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Cattle
- Swine
- Poultry
- Sheep and Goats
- Others (e.g., equine)
6. Global Veterinary API Market, By Formulation, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Solid
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Tablets
- Capsules
- Powders
- Semi solid
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Ointments
- Gels
- Liquid
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Injectables
- Oral Solutions/Suspensions
7. Global Veterinary API Market, By Therapeutic Application, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Infectious Disease Management
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Pain/Inflammation Management
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Parasitic Control
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Metabolic and Endocrine Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Reproductive Health
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Nutritional Support
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Anesthesia/Sedation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others (e.g., Dermatology)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
8. Global Veterinary API Market, By Route of Administration, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Parenteral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Mucosal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
9. Global Veterinary API Market, By Manufacturing Type, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Contract Manufacturing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- In house Manufacturing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
10. Global Veterinary API Market, By Sales Channel, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Online
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Offline
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
11. Global Veterinary API Market, By Region, 2021 - 2033, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Animal Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Formulation, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Manufacturing Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Sales Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Animal Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Formulation, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Manufacturing Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Sales Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Animal Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Formulation, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Manufacturing Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Sales Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Animal Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Formulation, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Manufacturing Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Sales Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Animal Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Formulation, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Manufacturing Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Sales Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Animal Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Formulation, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Manufacturing Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Sales Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
12. Competitive Landscape
- Zoetis Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- SUANFARMA S.A
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Grupo Indukern S.L
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sequent Scientific Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Ofichem Group
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Alivira Animal Health Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Excel Industries Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Chempro Pharma Private Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- NGL Fine Chem Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- FIS - Fabbrica Italiana Sintetici S.p.A
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AMGIS Lifescience Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Huvepharma AD
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Vetpharma Animal Health S.L
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Qilu Animal Health Products Co Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Menadiona
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
13. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
14. References and Research Methodology
- References
- Research Methodology
- About us
